VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
13 hedge funds and large institutions have $11.4M invested in Virpax Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
13
Holders Change
+6
Holders Change %
+85.71%
% of All Funds
0.23%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
9
Increased
3
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$4.77M |
| 2 |
KC
2
Kepos Capital
New York
|
$3.6M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$1.34M |
| 4 |
ACM
4
Altium Capital Management
New York
|
$1.31M |
| 5 |
5
Two Sigma Investments
New York
|
$123K |
Top Sellers
| 1 |
ZCA
1
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
$0 |
| 2 |
SC
2
Saltoro Capital
Dallas,
Texas
|
$0 |
| 3 |
VF
3
Virtu Financial
New York
|
$66K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$0 |
